Source:http://linkedlifedata.com/resource/pubmed/id/20870345
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0015127,
umls-concept:C0030705,
umls-concept:C0179586,
umls-concept:C0181090,
umls-concept:C0205314,
umls-concept:C0220825,
umls-concept:C0220934,
umls-concept:C0242485,
umls-concept:C0302614,
umls-concept:C0341439,
umls-concept:C0439611,
umls-concept:C0549193,
umls-concept:C0599755,
umls-concept:C0599946,
umls-concept:C0679622,
umls-concept:C1314792,
umls-concept:C1422073,
umls-concept:C1422760,
umls-concept:C1519941,
umls-concept:C1657858,
umls-concept:C1706050,
umls-concept:C1706092,
umls-concept:C1706433,
umls-concept:C2587213,
umls-concept:C2603343,
umls-concept:C2711227
|
pubmed:issue |
11
|
pubmed:dateCreated |
2010-10-25
|
pubmed:abstractText |
There is a need for noninvasive methods to detect liver steatosis, which can be a factor of liver fibrosis progression. This work aims to evaluate a novel ultrasonic controlled attenuation parameter (CAP) devised to target, specifically, liver steatosis using a sophisticated process based on vibration control transient elastography (VCTE™). CAP was first validated as an estimate of ultrasonic attenuation at 3.5 MHz using Field II simulations and tissue-mimicking phantoms. Performance of the CAP was then appraised on 115 patients, taking the histological grade of steatosis as reference. CAP was significantly correlated to steatosis (Spearman ? = 0.81, p < 10(-16)). Area under receiver operative characteristic (ROC) curve (AUC) was equal to 0.91 and 0.95 for the detection of more than 10% and 33% of steatosis, respectively. Furthermore, results show that CAP can efficiently separate several steatosis grades. These promising results suggest that CAP is a noninvasive, immediate, objective and efficient method to detect and quantify steatosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1879-291X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1825-35
|
pubmed:meshHeading |
pubmed-meshheading:20870345-Algorithms,
pubmed-meshheading:20870345-Area Under Curve,
pubmed-meshheading:20870345-Chronic Disease,
pubmed-meshheading:20870345-Cohort Studies,
pubmed-meshheading:20870345-Disease Progression,
pubmed-meshheading:20870345-Elasticity Imaging Techniques,
pubmed-meshheading:20870345-Fatty Liver,
pubmed-meshheading:20870345-Humans,
pubmed-meshheading:20870345-Phantoms, Imaging,
pubmed-meshheading:20870345-Pilot Projects,
pubmed-meshheading:20870345-ROC Curve,
pubmed-meshheading:20870345-Reproducibility of Results,
pubmed-meshheading:20870345-Statistics, Nonparametric
|
pubmed:year |
2010
|
pubmed:articleTitle |
Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.
|
pubmed:affiliation |
R&D Department, Echosens, Paris, France. magali.sasso@echosens.com
|
pubmed:publicationType |
Journal Article,
Validation Studies
|